P820: PREDICTING RESPONSE TO RABBIT ATG-BASED INTENSIVE IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG IN CHINESE ADULT PATIENTS WITH SEVERE APLASTIC ANEMIA

Ítems similars

• A Multicenter Retrospective Study Comparing Immunosuppressive Therapy Combined with Eltrombopag to Immunosuppressive Therapy Alone as Frontline Treatment for Pediatric Severe Aplastic Anemia
  per: Didem Atay, et al.
  Publicat: (2025-09-01)
• Idiopathic severe aplastic anemia with a delayed response to immunosuppressive therapy: a case report
  per: Nujood Alzahrani, et al.
  Publicat: (2018-06-01)
• A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte globulin (eATG)
  per: Biju George, et al.
  Publicat: (2026-01-01)
• Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
  per: Monica Carpenedo, et al.
  Publicat: (2024-12-01)
• The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults
  per: Agnieszka Piekarska, et al.
  Publicat: (2024-04-01)